Fluorine F 18 Choline

PreclinicalSmall molecule

UUniversity of California, San Francisco

Fluorine F 18 Choline is one of 14 small molecule programs targeting Hypoxia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

HypoxiaActive, not recruiting

HypoxiaPreclinical

Active, not recruiting

Competition

Competitive Landscape

20 competitors in Hypoxia

#DrugCompanyPhaseTrials

Actos

Takeda

Approved

1 2

Diamox

Teva

Approved

1 3

Inderal

WWyeth-Lederle Vaccines

Approved

1 4

Zyrtec

KKenvue Brands

Approved

1 5

Neptazane

WWyeth-Lederle Vaccines

Approved

2 6

Citicoline

UUniversity of Texas Southwestern Medical Center

Phase 3

1 7

Platinol

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 2

1 8

Nitrostat

VViatris Specialty LLC

Preclinical

1 9

Calcium

Eli Lilly

Preclinical

—10

Ciprofol

Haisco Pharmaceutical Group Co., Ltd.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Prostate Cancer1 trial

11C- and 18F-Choline PET/MR Imaging for Prostate Cancer

Completed·UUniversity of California, San Francisco·Phase 2·NCT02397408·18 enrolled

Hypoxia1 trial

Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell Therapy

Completed·UUniversity of California, San Francisco··NCT04409314·23 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Fluorine F 18 Choline. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Fluorine F 18 Choline compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Fluorine F 18 Choline. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of California, San Francisco company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of California, San Francisco

Fluorine F 18 Choline

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Prostate Cancer1 trial

Hypoxia1 trial

References

Drug Info

Quick Facts

Related News